Comparative study of tobramycin and gentamicin with special reference to anti‐Pseudomonas activity
Jean Klášterský, D. Daneau, Viviane De Maertelaer
Abstract
Jean Klášterský, D. Daneau, Viviane De Maertelaer
Abstract
Tobramycin was compared to gentamicin in vitro and was found more active on Pseudomonas aeruginosa. When tobramycin and gentamicin were administered to volunteers as a single intramuscular iniection (2 .. 5 mg. per kilogram), similar blood levels were observed (mean peak levels of 7.3 p.g per milliliter and 7.1 p.g per milliliter, respectively). Sera from these subiects was more active (p < 0.05) against strains of Ps. aeruginosa, which had similar susceptibility to tobramycin and gentamicin.
OpenAlex reports 17 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tobramycin was compared to gentamicin in vitro and was found more active on Pseudomonas aeruginosa. When tobramycin and gentamicin were administered to volunteers as a single intramuscular iniection (2 .. 5 mg. per kilogram), similar blood levels were observed (mean peak levels of 7.3 p.g per milliliter and 7.1 p.g per milliliter, respectively). Sera from these subiects was more active (p < 0.05) against strains of Ps. aeruginosa, which had similar susceptibility to tobramycin and gentamicin.
Key concepts: Tobramycin, Gentamicin, Pseudomonas aeruginosa, Liter, Aminoglycoside, Microbiology, Pseudomonas, Antibiotics